424 related articles for article (PubMed ID: 37526673)
21. The potential roles and mechanisms of non-coding RNAs in cancer anoikis resistance.
Shi T; Zhang C; Xia S
Mol Cell Biochem; 2022 May; 477(5):1371-1380. PubMed ID: 35142950
[TBL] [Abstract][Full Text] [Related]
22. Non-coding RNAs and gastric cancer.
Li PF; Chen SC; Xia T; Jiang XM; Shao YF; Xiao BX; Guo JM
World J Gastroenterol; 2014 May; 20(18):5411-9. PubMed ID: 24833871
[TBL] [Abstract][Full Text] [Related]
23. HER2 puzzle pieces: Non-Coding RNAs as keys to mechanisms, chemoresistance, and clinical outcomes in Ovarian cancer.
Yang F; Yan L; Ji J; Lou Y; Zhu J
Pathol Res Pract; 2024 Jun; 258():155335. PubMed ID: 38723327
[TBL] [Abstract][Full Text] [Related]
24. Non-coding RNAs in the reprogramming of glucose metabolism in cancer.
Shankaraiah RC; Veronese A; Sabbioni S; Negrini M
Cancer Lett; 2018 Apr; 419():167-174. PubMed ID: 29366802
[TBL] [Abstract][Full Text] [Related]
25. Non-coding RNAs in cardiovascular cell biology and atherosclerosis.
Fasolo F; Di Gregoli K; Maegdefessel L; Johnson JL
Cardiovasc Res; 2019 Oct; 115(12):1732-1756. PubMed ID: 31389987
[TBL] [Abstract][Full Text] [Related]
26. Non-coding RNAs and exosomal ncRNAs in multiple myeloma: An emphasis on molecular pathways.
Hashemi M; Roshanzamir SM; Paskeh MDA; Karimian SS; Mahdavi MS; Kheirabad SK; Naeemi S; Taheriazam A; Salimimoghaddam S; Entezari M; Mirzaei S; Samarghandian S
Eur J Pharmacol; 2023 Feb; 941():175380. PubMed ID: 36627099
[TBL] [Abstract][Full Text] [Related]
27. Non-coding RNAs as Novel Biomarkers in Cancer Drug Resistance.
Yang H; Qi C; Li B; Cheng L
Curr Med Chem; 2022; 29(5):837-848. PubMed ID: 34348605
[TBL] [Abstract][Full Text] [Related]
28. ncRNADrug: a database for validated and predicted ncRNAs associated with drug resistance and targeted by drugs.
Cao X; Zhou X; Hou F; Huang YE; Yuan M; Long M; Chen S; Lei W; Zhu J; Chen J; Zhang T; Guo AY; Jiang W
Nucleic Acids Res; 2024 Jan; 52(D1):D1393-D1399. PubMed ID: 37953323
[TBL] [Abstract][Full Text] [Related]
29. RNA inhibition, microRNAs, and new therapeutic agents for cancer treatment.
Spizzo R; Rushworth D; Guerrero M; Calin GA
Clin Lymphoma Myeloma; 2009; 9 Suppl 3():S313-8. PubMed ID: 19778859
[TBL] [Abstract][Full Text] [Related]
30. Non-Coding RNA Signatures of B-Cell Acute Lymphoblastic Leukemia.
Rodriguez PD; Paculova H; Kogut S; Heath J; Schjerven H; Frietze S
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33799946
[TBL] [Abstract][Full Text] [Related]
31. Non-coding RNAs derailed: The many influences on the fatty acid reprogramming of cancer.
Yu XH; Wang HF; Wu JB; Wang SS; Tang YJ; Tang YL; Liang XH
Life Sci; 2019 Aug; 231():116509. PubMed ID: 31152812
[TBL] [Abstract][Full Text] [Related]
32. Emerging roles of non-coding RNAs in colorectal cancer oxaliplatin resistance and liquid biopsy potential.
Luo ZD; Wang YF; Zhao YX; Yu LC; Li T; Fan YJ; Zeng SJ; Zhang YL; Zhang Y; Zhang X
World J Gastroenterol; 2023 Jan; 29(1):1-18. PubMed ID: 36683709
[TBL] [Abstract][Full Text] [Related]
33. Noncoding RNA and colorectal cancer: its epigenetic role.
Kita Y; Yonemori K; Osako Y; Baba K; Mori S; Maemura K; Natsugoe S
J Hum Genet; 2017 Jan; 62(1):41-47. PubMed ID: 27278790
[TBL] [Abstract][Full Text] [Related]
34. Role of Hedgehog and Hippo signaling pathways in cancer: A special focus on non-coding RNAs.
Sharma U; Tuli HS; Uttam V; Choudhary R; Sharma B; Sharma U; Prakash H; Jain A
Pharmacol Res; 2022 Dec; 186():106523. PubMed ID: 36377125
[TBL] [Abstract][Full Text] [Related]
35. Role of hedgehog signaling related non-coding RNAs in developmental and pathological conditions.
HajiEsmailPoor Z; Tabnak P; Ahmadzadeh B; Ebrahimi SS; Faal B; Mashatan N
Biomed Pharmacother; 2022 Sep; 153():113507. PubMed ID: 36076513
[TBL] [Abstract][Full Text] [Related]
36. Dual Effects of Non-Coding RNAs (ncRNAs) in Cancer Stem Cell Biology.
Kyriazi AA; Papiris E; Kitsos Kalyvianakis K; Sakellaris G; Baritaki S
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32932969
[TBL] [Abstract][Full Text] [Related]
37. Unveiling the role of ferroptosis-associated exosomal non-coding RNAs in cancer pathogenesis.
Zhang Y; Xie J
Biomed Pharmacother; 2024 Mar; 172():116235. PubMed ID: 38308967
[TBL] [Abstract][Full Text] [Related]
38. Combinatorial epigenetic regulation of non-coding RNAs has profound effects on oncogenic pathways in breast cancer subtypes.
Xu J; Wang Z; Li S; Chen J; Zhang J; Jiang C; Zhao Z; Li J; Li Y; Li X
Brief Bioinform; 2018 Jan; 19(1):52-64. PubMed ID: 27742663
[TBL] [Abstract][Full Text] [Related]
39. [Regulatory mechanism of long noncoding RNA in the occurrence and development of leukemia: a review].
Li T; Hong J; Ma Y; Yang B; Wang G; Wang S; Chen J; Chi X
Sheng Wu Gong Cheng Xue Bao; 2021 Nov; 37(11):3933-3944. PubMed ID: 34841796
[TBL] [Abstract][Full Text] [Related]
40. Non-coding RNAs in lung cancer: emerging regulators of angiogenesis.
Liao Y; Wu X; Wu M; Fang Y; Li J; Tang W
J Transl Med; 2022 Aug; 20(1):349. PubMed ID: 35918758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
